A novel quinazolinone chalcone derivative induces mitochondrial dependent apoptosis and inhibits PI3K/Akt/mTOR signaling pathway in human colon cancer HCT-116 cells. (January 2016)
- Record Type:
- Journal Article
- Title:
- A novel quinazolinone chalcone derivative induces mitochondrial dependent apoptosis and inhibits PI3K/Akt/mTOR signaling pathway in human colon cancer HCT-116 cells. (January 2016)
- Main Title:
- A novel quinazolinone chalcone derivative induces mitochondrial dependent apoptosis and inhibits PI3K/Akt/mTOR signaling pathway in human colon cancer HCT-116 cells
- Authors:
- Wani, Zahoor Ahmad
Guru, Santosh Kumar
Rao, A.V. Subba
Sharma, Sonia
Mahajan, Girish
Behl, Akanksha
Kumar, Ashok
Sharma, P.R.
Kamal, Ahmed
Bhushan, Shashi
Mondhe, Dilip M. - Abstract:
- Abstract: We have synthesized a novel quinazolinone chalcone derivative (QC) and first time reported its in-vitro and in-vivo anticancer potential. It inhibited the cell proliferation of different cancer cell lines like PC-3, Panc-1, Mia-Paca-2, A549, MCF-7 and HCT-116. It induces apoptosis as measured by several biological endpoints such as apoptotic body formation, evident by Hoechst and scanning electron microscopy, enhanced annexinV-FITC binding of the cells, increased sub-G0 cell fraction, loss of mitochondrial membrane potential (Δψm), reduction of Bcl-2/Bax ratio, activation of caspase-9, caspase-3 and PARP-1 (poly-ADP Ribose polymerase) cleavage in HCT-116 cells. In spite of apoptosis, QC significantly hammers the downstream and upstream signaling cascade of PI3K/Akt/mTOR pathway and cell cycle regulator Skp-2, p21 and p27. Interestingly, QC induces the S and G2/M phase of HCT-116 cells at experimental doses. QC inhibits the tumor growth of Ehrlich ascites carcinoma (EAC), Ehrlich tumor (ET, solid) and sarcoma-180(solid) mice models. Furthermore, it was found to be non-toxic as no animal mortality (0/7) occurred during experimental doses. The present study provides an insight of anticancer potential of QC, which may be useful in managing and treating cancer. Graphical abstract: Highlights: We have synthesized a novel quinazolinone-chalcone derivative, QC. It inhibits PI3K/Akt/mTOR pathway. It induces mitochondrial dependant apoptosis. It inhibits the growth of EAC,Abstract: We have synthesized a novel quinazolinone chalcone derivative (QC) and first time reported its in-vitro and in-vivo anticancer potential. It inhibited the cell proliferation of different cancer cell lines like PC-3, Panc-1, Mia-Paca-2, A549, MCF-7 and HCT-116. It induces apoptosis as measured by several biological endpoints such as apoptotic body formation, evident by Hoechst and scanning electron microscopy, enhanced annexinV-FITC binding of the cells, increased sub-G0 cell fraction, loss of mitochondrial membrane potential (Δψm), reduction of Bcl-2/Bax ratio, activation of caspase-9, caspase-3 and PARP-1 (poly-ADP Ribose polymerase) cleavage in HCT-116 cells. In spite of apoptosis, QC significantly hammers the downstream and upstream signaling cascade of PI3K/Akt/mTOR pathway and cell cycle regulator Skp-2, p21 and p27. Interestingly, QC induces the S and G2/M phase of HCT-116 cells at experimental doses. QC inhibits the tumor growth of Ehrlich ascites carcinoma (EAC), Ehrlich tumor (ET, solid) and sarcoma-180(solid) mice models. Furthermore, it was found to be non-toxic as no animal mortality (0/7) occurred during experimental doses. The present study provides an insight of anticancer potential of QC, which may be useful in managing and treating cancer. Graphical abstract: Highlights: We have synthesized a novel quinazolinone-chalcone derivative, QC. It inhibits PI3K/Akt/mTOR pathway. It induces mitochondrial dependant apoptosis. It inhibits the growth of EAC, EAT and Sarcoma-180 tumors without any side effects. … (more)
- Is Part Of:
- Food and chemical toxicology. Volume 87(2016)
- Journal:
- Food and chemical toxicology
- Issue:
- Volume 87(2016)
- Issue Display:
- Volume 87, Issue 2016 (2016)
- Year:
- 2016
- Volume:
- 87
- Issue:
- 2016
- Issue Sort Value:
- 2016-0087-2016-0000
- Page Start:
- 1
- Page End:
- 11
- Publication Date:
- 2016-01
- Subjects:
- Quinazolinone-chalcone -- Apoptosis -- PI3K/Akt/mTOR -- Sarcoma-180
QC Quinazolinone-chalcone -- Δψm mitochondrial membrane potential -- MTT 3-(4, 5-dimethylthiazole-2-yl)-2, 5-diphenyltetrazolium bromide -- PI propidium iodide -- PTP mitochondrial permeability transition pore -- Rh-123 Rhodamine- 123 -- PBS phosphate buffer saline -- PARP poly-ADP-ribose polymerase -- mTOR mammalian target of rapamycin -- DMEM Dulbecco's Modified Eagle's medium -- RPMI Roswell Park Memorial Institute -- MEM Minimum Essential Medium -- EAC Ehrlich Ascites Carcinoma -- ET Ehrlich Ascites tumor -- S-180 sarcoma-180
Toxicology -- Periodicals
Food poisoning -- Periodicals
Food Poisoning -- Periodicals
Toxicology -- Periodicals
Toxicologie -- Périodiques
Intoxications alimentaires -- Périodiques
Food poisoning
Toxicology
Periodicals
Electronic journals
615.9 - Journal URLs:
- http://www.sciencedirect.com/science/journal/02786915 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.fct.2015.11.016 ↗
- Languages:
- English
- ISSNs:
- 0278-6915
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3977.026900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 7600.xml